Time: 19:00 - 20:00
Location: Room IX, Palais des Nations, Geneva
Innovative health technologies are the most cost-effective solutions to achieve the Sustainable Development Goals (SDGs), as they have the potential to save millions of lives. Research and development (R&D) for new health tools may play a critical role not only in ensuring healthy lives (SDG 3), but also in relieving poverty (SDG 1), contributing to drive economic growth (SDG 8), strengthening partnerships (SDG 17) and enhancing global health security.
Over the past few years, investments in global health R&D have delivered new health technologies that address a multitude of poverty related and neglected diseases (PRNDs), which affect the most vulnerable populations. However, despite tremendous progress and millions of lives saved, PRNDs are still major killers. Furthermore, antimicrobial resistance is a major global concern. Thus, current global health R&D efforts are not enough to combat those threats and achieve the SDGs—new drugs, diagnostics, vaccines and health tools are urgently needed to tackle those global diseases.
How can governments work with each other, the private sector, and civil society to develop and scale innovative health technologies to address PRNDs and antimicrobial resistance? What is needed to support efforts of low- and middle-income countries to improve domestic resource mobilization efforts and develop sustainable, long-term funding for global health innovation? How can global health R&D contribute to achieving the SDGs, including health outcomes, national economic growth, and global cooperation? How can we galvanize support from G20 countries to include health R&D in the global political agenda and discussions?
The session will be moderated by M.P. Matsoso, Director-General of Health, Ministry of Health of South
To be admitted to this event, participants must hold a valid security pass for the Palais des Nations.
For more information, contact dopacoc [at] mmv.org (Christina do Paço), Medicines for Malaria Venture